This application requests continued funding for a research training program in hematology that has been successful in attracting young physician-scientists into academic medicine. The program has as its primary objective to prepare MD, MD/PhD, and PhD postdoctoral fellows for productive careers as academic scientists and physician-scientists. The focus of training supported by this grant remains within the scientific discipline of hematology. An evolving feature of the training program is an expanded emphasis to provide training opportunities in translational research. The training will be carried out in an enriched environment of active basic and clinical investigation at an institution that emphasizes the career development of physician scientists. The specific objectives are: 1) To identify and recruit outstanding postdoctoral trainees, inclusive of gender and ethnicity, who wish to obtain comprehensive knowledge of the principles and techniques of basic or translational research related to hematology;2) To attract highly motivated clinicians to enter careers as physician-scientists and provide them with comprehensive instruction in the design and implementation of high quality research projects, including participation in cross-disciplinary research teams;3) To train physician-scientists for academic careers in hematology and related scientific disciplines and prepare them for a successful transition to independence;4) To expose talented Ph.D. scientists to the field of hematology and train them for careers as independent investigators. Since the last renewal, the training program has undergone a transition to new leadership and several new initiatives have been instituted. These include a formal external review process, the establishment of a mentoring committee for each trainee, and the implementation of several new strategies to improve the recruitment of trainees from underrepresented minority groups. The rich training environment provided by the diverse faculty, extensive laboratory, clinical, and core facilities, and strong institutional support should ensure continued success in attracting and preparing highly qualified postdoctoral trainees for careers in academic hematology.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Chang, Henry
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Iowa
Internal Medicine/Medicine
Schools of Medicine
Iowa City
United States
Zip Code
Baack, Michelle L; Wang, Chunlin; Hu, Shanming et al. (2014) Hyperglycemia induces embryopathy, even in the absence of systemic maternal diabetes: an in vivo test of the fuel mediated teratogenesis hypothesis. Reprod Toxicol 46:129-36
Dassie, Justin P; Hernandez, Luiza I; Thomas, Gregory S et al. (2014) Targeted inhibition of prostate cancer metastases with an RNA aptamer to prostate-specific membrane antigen. Mol Ther 22:1910-22
Peterson, Tabitha A; Stamnes, Mark (2013) ARF1-regulated coatomer directs the steady-state localization of protein kinase C epsilon at the Golgi apparatus. Biochim Biophys Acta 1833:487-93
Thiel, Kristina W; Hernandez, Luiza I; Dassie, Justin P et al. (2012) Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers. Nucleic Acids Res 40:6319-37
Holstein, Sarah A; Hohl, Raymond J (2011) Isoprenoid biosynthetic pathway inhibition disrupts monoclonal protein secretion and induces the unfolded protein response pathway in multiple myeloma cells. Leuk Res 35:551-9
Raife, Thomas J; Dwyre, Denis M; Stevens, Jeff W et al. (2011) Human thrombomodulin knock-in mice reveal differential effects of human thrombomodulin on thrombosis and atherosclerosis. Arterioscler Thromb Vasc Biol 31:2509-17
Rowland, Sarah L; Tremblay, Mikaela M; Ellison, Jason M et al. (2007) A novel mechanism for TNFR-associated factor 6-dependent CD40 signaling. J Immunol 179:4645-53
Swanson, Kelly M; Hohl, Raymond J (2006) Anti-cancer therapy: targeting the mevalonate pathway. Curr Cancer Drug Targets 6:15-37
Miller, Michal A; Ohashi, Kensuke; Zhu, Xiaoyan et al. (2006) Survivin mRNA levels are associated with biology of disease and patient survival in neuroblastoma: a report from the children's oncology group. J Pediatr Hematol Oncol 28:412-7
Miller, Michal A; Karacay, Bahri; Breslow, Norman E et al. (2005) Prognostic value of quantifying apoptosis factor expression in favorable histology wilms tumors. J Pediatr Hematol Oncol 27:11-4

Showing the most recent 10 out of 48 publications